✦ LIBER ✦

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

✍ Scribed by Bild, Andrea H.; Yao, Guang; Chang, Jeffrey T.; Wang, Quanli; Potti, Anil; Chasse, Dawn; Joshi, Mary-Beth; Harpole, David; Lancaster, Johnathan M.; Berchuck, Andrew

Book ID: 109895436
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 476 KB
Volume: 439
Category: Article
ISSN: 0028-0836
DOI: 10.1038/nature04296

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted Molecular Strategies for Cancer

Targeted Molecular Strategies for Cancer Therapy Based on the Blockade of Oncogenic Pathways in Human Tumor Cells

✍ Kei-ichi Ozaki 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

Tumour angiogenesis as a target for aden

Tumour angiogenesis as a target for adenoviral mediated antisense gene therapy in human prostate cancer

✍ Wood, C G 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

The estrogen receptor (ER) as a novel ta

The estrogen receptor (ER) as a novel target for therapeutics in breast cancer cell refractory to antihormone therapy

✍ S. Lim; B. Amundsen; S. Pearce; M. Chang; V. C. Jordan 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 150 KB

Specific binding of TES-23 antibody to t

Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

✍ Tsunoda, S; Ohizumi, I; Matsui, J; Koizumi, K; Wakai, Y; Makimoto, H; Tsutsumi, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 542 KB

Identification of p27/KIP1 expression le

Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer

✍ Guang Chen; Na Yang; Xiang Wang; Si-Yuan Zheng; Yi Chen; Lin-Jiang Tong; Yi-Xue 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 460 KB

Ratio of baseline erythropoietin (EPO) l

Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients

✍ Navapun Charuruks; Narin Voravud; Wacharee Limpanasithikul 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Purpose: Recently, recombinant human erythropoietin (rhEPO) was introduced for the management of anemia in malignancy. To identify an indicator for a favourable response to rhEPO, 28 anaemic cancer patients undergoing chemotherapy and treated with rhEPO were evaluated. Methods: Patients